HeartBeam Stock (NASDAQ:BEAT)

HeartBeam, Inc. is a medical technology firm specializing in remote cardiac care. The company provides telemedicine solutions designed to diagnose and monitor heart conditions outside of traditional healthcare facilities. Their offerings empower physicians with vital diagnostic data, enabling effective management of patients with cardiovascular disease. At the core of their telehealth product is a compact, credit card-sized electrocardiogram (ECG) device, seamlessly integrated with a cloud-based diagnostic software platform. This innovative system addresses the rapidly expanding need for remote patient monitoring. HeartBeam, Inc. was established in 2015 and is headquartered in Santa Clara, California.